Integrated Advisors Network LLC Purchases Shares of 2,936 HealthEquity, Inc. (NASDAQ:HQY)

Integrated Advisors Network LLC acquired a new position in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 2,936 shares of the company's stock, valued at approximately $259,000.

A number of other large investors have also recently made changes to their positions in the company. Arcadia Investment Management Corp MI bought a new stake in shares of HealthEquity in the 4th quarter valued at about $26,000. Versant Capital Management Inc bought a new stake in shares of HealthEquity in the 1st quarter valued at about $28,000. Transce3nd LLC bought a new stake in shares of HealthEquity in the 4th quarter valued at about $29,000. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares in the last quarter. Finally, Proficio Capital Partners LLC bought a new stake in shares of HealthEquity in the 4th quarter valued at about $39,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

HealthEquity Stock Performance

HealthEquity stock traded up $0.77 during mid-day trading on Friday, reaching $104.76. 854,492 shares of the company traded hands, compared to its average volume of 836,913. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity, Inc. has a fifty-two week low of $65.01 and a fifty-two week high of $116.65. The company has a market capitalization of $9.06 billion, a price-to-earnings ratio of 96.11, a price-to-earnings-growth ratio of 1.60 and a beta of 0.49. The firm's fifty day moving average is $93.96 and its two-hundred day moving average is $97.86.

HealthEquity (NASDAQ:HQY - Get Free Report) last issued its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. The business had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the business posted $0.80 EPS. On average, equities research analysts expect that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have recently commented on HQY shares. Deutsche Bank Aktiengesellschaft boosted their price target on shares of HealthEquity from $98.00 to $115.00 and gave the company a "buy" rating in a report on Thursday, June 5th. The Goldman Sachs Group boosted their price target on shares of HealthEquity from $94.00 to $104.00 and gave the company a "neutral" rating in a report on Wednesday, June 4th. Wall Street Zen raised shares of HealthEquity from a "hold" rating to a "buy" rating in a research report on Friday, June 6th. Royal Bank of Canada lifted their price objective on shares of HealthEquity from $112.00 to $117.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 4th. Finally, KeyCorp cut their price objective on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday, April 16th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Buy" and an average target price of $118.09.

Insider Activity

In related news, Director Jon Kessler sold 134,183 shares of the stock in a transaction on Friday, June 6th. The shares were sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the sale, the director now directly owns 253,510 shares of the company's stock, valued at approximately $28,413,400.80. This represents a 34.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total transaction of $695,027.06. Following the sale, the executive vice president now directly owns 56,655 shares in the company, valued at $4,433,820.30. This trade represents a 13.55% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 304,581 shares of company stock valued at $33,664,018 in the last ninety days. Insiders own 1.50% of the company's stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.